T77022
Gefurulimab
TargetMol
DESCRIPTION
Gefurulimab (ALXN-1720) is a bispecific antibody derived from humans, targeting complement C5 and albumin. It specifically binds to C5, inhibiting its activation [1].
DETAILS
- Cas: 2456407-94-4
- Purity: 98%
- Category: Compound
Lead Time: 4 - 5 weeks
Sign in to view pricingEquivalent Items
| ... Loading